1. Home
  2. LINK vs XLO Comparison

LINK vs XLO Comparison

Compare LINK & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Interlink Electronics Inc.

LINK

Interlink Electronics Inc.

N/A

Current Price

$3.19

Market Cap

64.7M

Sector

Technology

ML Signal

N/A

XLO

Xilio Therapeutics Inc.

N/A

Current Price

$8.60

Market Cap

56.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LINK
XLO
Founded
1984
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
64.7M
56.9M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
LINK
XLO
Price
$3.19
$8.60
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
N/A
★ $18.00
AVG Volume (30 Days)
★ 21.7K
14.4K
Earning Date
11-16-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 45.83
N/A
EPS
★ N/A
N/A
Revenue
$11,890,000.00
★ $43,766,000.00
Revenue This Year
$40.45
N/A
Revenue Next Year
$19.16
$23.90
P/E Ratio
★ N/A
N/A
Revenue Growth
1.81
★ 589.88
52 Week Low
$2.66
$0.46
52 Week High
$6.50
$23.49

Technical Indicators

Market Signals
Indicator
LINK
XLO
Relative Strength Index (RSI) 26.80 50.12
Support Level $2.87 $7.29
Resistance Level $3.38 $9.35
Average True Range (ATR) 0.30 0.74
MACD -0.08 0.08
Stochastic Oscillator 12.01 71.00

Price Performance

Historical Comparison
LINK
XLO

About LINK Interlink Electronics Inc.

Interlink Electronics Inc is a provider of sensing technologies and printed electronics solutions that enable Human-Machine Interface (HMI) devices and Internet-of-Things (IoT) applications. Its broad product and technology portfolio spans force and touch sensors, piezoelectric sensors, rugged HMI sensors, wearable and textile-based sensors and electrochemical gas and environmental sensors, along with instruments and fully integrated systems based on its sensor technologies. It serves blue-chip customers and emerging companies across diverse end-use markets, including medical, industrial, automotive, consumer electronics, wearables, environmental monitoring, and specialty applications. It operates in single segment: the design, development, and manufacture of sensor technologies.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: